These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 29127370

  • 21. A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer.
    Abdollahi A, Rahmati S, Ghaderi B, Sigari N, Nikkhoo B, Sharifi K, Abdi M.
    QJM; 2019 Oct 01; 112(10):779-785. PubMed ID: 31236600
    [Abstract] [Full Text] [Related]

  • 22. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.
    Xia J, Luo M, Dai L, Wang L, Wang L, Zhu J.
    J Clin Lab Anal; 2021 May 01; 35(5):e23743. PubMed ID: 33682961
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N, Kawamura M.
    Oncology; 2018 May 01; 94(5):311-323. PubMed ID: 29533963
    [Abstract] [Full Text] [Related]

  • 24. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma.
    Feng M, Zhao J, Wang L, Liu J.
    Ann Clin Lab Sci; 2018 Nov 01; 48(6):712-718. PubMed ID: 30610040
    [Abstract] [Full Text] [Related]

  • 25. A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.
    Monastirioti A, Papadaki C, Rounis K, Kalapanida D, Mavroudis D, Agelaki S.
    Cells; 2021 Aug 05; 10(8):. PubMed ID: 34440757
    [Abstract] [Full Text] [Related]

  • 26. Role of circulating microRNAs in non-small cell lung carcinoma.
    Baranwal H, Mishra SK, Kumari N, Singh S, Krishnani N, Nath A, Neyaz Z.
    Indian J Pathol Microbiol; 2024 Jul 01; 67(3):502-509. PubMed ID: 38391370
    [Abstract] [Full Text] [Related]

  • 27. Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
    Pan C, Stevic I, Müller V, Ni Q, Oliveira-Ferrer L, Pantel K, Schwarzenbach H.
    Mol Oncol; 2018 Nov 01; 12(11):1935-1948. PubMed ID: 30107086
    [Abstract] [Full Text] [Related]

  • 28. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y, Tang Y, Yang Z, Wu F, Wang L, Yang L, Lei L, Jing Y, Jiang X, Jin H, Bai Y, Zhang L.
    Int J Biol Sci; 2020 Nov 01; 16(3):471-482. PubMed ID: 32015683
    [Abstract] [Full Text] [Related]

  • 29. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
    Gao J, Qiu X, Li X, Fan H, Zhang F, Lv T, Song Y.
    Biochem Biophys Res Commun; 2018 Apr 06; 498(3):409-415. PubMed ID: 29452091
    [Abstract] [Full Text] [Related]

  • 30. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.
    Wang H, Hou L, Li A, Duan Y, Gao H, Song X.
    Biomed Res Int; 2014 Apr 06; 2014():864894. PubMed ID: 24963487
    [Abstract] [Full Text] [Related]

  • 31. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.
    Eur Urol Focus; 2018 Apr 06; 4(3):412-419. PubMed ID: 28753793
    [Abstract] [Full Text] [Related]

  • 32. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.
    J Thorac Oncol; 2011 Mar 06; 6(3):482-8. PubMed ID: 21258252
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X, Le H, Zhang Y.
    PLoS One; 2016 Mar 06; 11(4):e0153046. PubMed ID: 27093275
    [Abstract] [Full Text] [Related]

  • 34. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer.
    Zou JG, Ma LF, Li X, Xu FL, Fei XZ, Liu Q, Bai QL, Dong YL.
    Eur Rev Med Pharmacol Sci; 2019 Feb 06; 23(3):1108-1115. PubMed ID: 30779079
    [Abstract] [Full Text] [Related]

  • 35. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
    Yang JS, Li BJ, Lu HW, Chen Y, Lu C, Zhu RX, Liu SH, Yi QT, Li J, Song CH.
    Tumour Biol; 2015 Apr 06; 36(4):3035-42. PubMed ID: 25501703
    [Abstract] [Full Text] [Related]

  • 36. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
    Roth C, Stückrath I, Pantel K, Izbicki JR, Tachezy M, Schwarzenbach H.
    PLoS One; 2012 Apr 06; 7(6):e38248. PubMed ID: 22675530
    [Abstract] [Full Text] [Related]

  • 37. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
    Zhang YK, Sun B, Sui G.
    Genet Mol Res; 2016 Aug 12; 15(3):. PubMed ID: 27525941
    [Abstract] [Full Text] [Related]

  • 38. Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer.
    D'Antona P, Cattoni M, Dominioni L, Poli A, Moretti F, Cinquetti R, Gini E, Daffrè E, Noonan DM, Imperatori A, Rotolo N, Campomenosi P.
    Cancer Epidemiol Biomarkers Prev; 2019 Nov 12; 28(11):1926-1933. PubMed ID: 31488416
    [Abstract] [Full Text] [Related]

  • 39. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q, Fan T, Zhang B, Wang W, Xu Y, Hu H.
    Respir Res; 2014 Nov 25; 15(1):149. PubMed ID: 25421010
    [Abstract] [Full Text] [Related]

  • 40. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G, Zhang J, Chen X.
    J Drug Target; 2016 Aug 25; 24(7):613-7. PubMed ID: 26581116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.